cbdMD Analyst Price Targets

Wall Street analyst price targets and consensus rating for cbdMD (YCBD).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Hold

Consensus RatingBuy# Analysts1Avg. Consensus PT$2Upside to Avg. PT+397.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 17, 2026	Maxim Group	Anthony Vendetti	Downgrade	Buy→Hold	—
Aug 20, 2025	Maxim Group	Tom McGovern	PT Cut	Buy	$3→$2
May 22, 2025	Maxim Group	Tom McGovern	PT Cut	Buy	$16→$3

Analyst Ratings News

PRO
Maxim Group Downgrades cbdMD to Hold

Maxim Group analyst Anthony Vendetti downgrades cbdMD (AMEX:YCBD) from Buy to Hold.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on cbdMD, Lowers Price Target to $2

Maxim Group analyst Tom McGovern maintains cbdMD (AMEX:YCBD) with a Buy and lowers the price target from $3 to $2.

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On cbdMD with Buy Rating, Announces Price Target of $3

Maxim Group analyst Anthony Vendetti initiates coverage on cbdMD (AMEX:YCBD) with a Buy rating and announces Price Target of $3.

Benzinga Newsdesk

Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens

Cantor Fitzgerald released a new report analyzing the possible effects of CBD reform in the stock performance of Charlotte's Web Holdings (TSX: CWEB) (OTCQX: CWBHF), cbdMD (NYSE:

Natan Ponieman

Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences

Cantor Fitzgerald’s Pablo Zuanic provided updated ratings and estimates on several stocks from the cannabis and CBD sector, those being – MedMen Enterprises (OTCQF:

Nina Zdinjak

10 Biggest Price Target Changes For Friday

Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading.

Lisa Levin

cbdMD Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

cbdMD Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Downgrades cbdMD to Hold

PRO
Maxim Group Maintains Buy on cbdMD, Lowers Price Target to $2

PRO
Maxim Group Initiates Coverage On cbdMD with Buy Rating, Announces Price Target of $3

Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens

Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences

10 Biggest Price Target Changes For Friday

People Also Watch

People Also Watch

cbdMD Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

cbdMD Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Downgrades cbdMD to Hold

PROMaxim Group Maintains Buy on cbdMD, Lowers Price Target to $2

PROMaxim Group Initiates Coverage On cbdMD with Buy Rating, Announces Price Target of $3

Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens

Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences

10 Biggest Price Target Changes For Friday

People Also Watch

People Also Watch

PRO
Maxim Group Downgrades cbdMD to Hold

PRO
Maxim Group Maintains Buy on cbdMD, Lowers Price Target to $2

PRO
Maxim Group Initiates Coverage On cbdMD with Buy Rating, Announces Price Target of $3